EUVIMED · CrossrefZeitschrift
JNCI: Journal of the National Cancer Institute
ISSN 0027-8874 · Oxford University Press (OUP)
Neueste Artikel
Correction to: Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab
Correction to: Breast implant illness after reconstruction with silicone breast implants
Pretreatment cognitive screening, treatment tolerability, and early mortality in older adults with advanced cancer initiating systemic therapy
Occupational solar ultraviolet radiation exposure and incident ocular melanoma risk in two large-scale nordic cohorts
US geographical disparities in young-onset colorectal cancer mortality, 1990–2023
Advancing gastric cancer prevention in the United States: perspectives from a congressional forum
The ethical dilemma of excluding patients from clinical trials based on language preference
The risk of gastric mucosa-associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication treatment
Treatment-related neutropenia as predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Pragmatic Trials Funded by the National Cancer Institute, 2009-2023: A Portfolio Analysis
Modeling neoadjuvant treatment plus additional therapy effects on US population breast cancer mortality
Electronic health record embedded frailty index and outcomes among older adults receiving cancer chemotherapy
Translating absolute risk of breast cancer into screening frequency: a framework to guide practice
Re: Liver cancer risk in the context of today’s hormonal contraceptives
Glycoprotein nonmetastatic melanoma protein B overexpression—a marker of resistance to cyclin-dependent kinase 4 and 6 inhibitors
Response to Lehrer and Rheinstein
Antibody drug conjugate efficacy: are we measuring the right treatment effect?
RE: De-escalation trials do not always need to be noninferiority: a case for superiority design de-escalation trials in oncology
Micro[nano]plastic particles and cancer: challenges and opportunities for epidemiology studies
The impact of the changing landscape of NIH funding for the cancer prevention and control research enterprise
International Network for Sinonasal Cancer Research: a collaborative group to advance research and clinical trials for rare sinonasal malignancies
Making human derived data FAIR: feedback from NCI office of data sharing workshop
Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study
Age- and sex-adjusted performance of a colorectal cancer screening test using US census distribution
Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a prospective cohort study
Implementation of smoking cessation interventions in real-world lung cancer screening: a RE-AIM–guided scoping review
RE: Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a prospective cohort study
Response to Chen and Tian
Statins and risk of cardiovascular disease: emulating a primary prevention trial in breast cancer survivors
Toxicity-over-time analysis of anti–epidermal growth factor receptor–based maintenance vs intermittent in left-sided RAS and BRAF wild-type metastatic colorectal cancer
Jahrgänge
2026 · 4322025 · 4252024 · 2942023 · 2422022 · 2722021 · 2732020 · 1962019 · 2232018 · 2252017 · 2812016 · 3402015 · 4142014 · 4972013 · 4782012 · 5282011 · 5402010 · 5732009 · 5022008 · 4882007 · 4942006 · 4992005 · 5802004 · 6072003 · 4942002 · 1252001 · 6342000 · 2661999 · 6591998 · 6051997 · 4991996 · 6711995 · 6731994 · 7281993 · 7401992 · 7771991 · 7391990 · 7691989 · 6741988 · 5011987 · 50
EUVIMED